Maturitas
Volume 55, Issue 4 , Pages 308-316 , 20 November 2006

The prescription of hormone replacement therapy in Spain: Differences between general practitioners and gynaecologists

  • Camil Castelo-Branco

      Affiliations

    • Hospital Clínic, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain
    • Corresponding Author InformationCorresponding author.
    • ,
  • Javier Ferrer

      Affiliations

    • Hospital Clínic, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain
    • University of Oviedo, Spain
    • ,
  • Santiago Palacios

      Affiliations

    • Hospital Clínic, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain
    • Instituto Palacios, Madrid, Spain
    • ,
  • Sonia Cornago

      Affiliations

    • Hospital Clínic, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain

Received 12 January 2006 ,Revised 11 April 2006 ,Accepted 11 April 2006.

References 

  1. Michels KB. Hormone replacement therapy in epidemiologic studies and randomized clinical trials—are we checkmate?. Epidemiology. 2003;14:3–5
  2. Giannakakis IA, Haidich AB, Contopoulos-Ioannidis DG, Papanikolaou GN, Baltogianni MS, Ioannidis JP. Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions. J Clin Epidemiol. 2002;55:545–555
  3. Laine C. Postmenopausal hormone replacement therapy: how could we have been so wrong?. Ann Intern Med. 2002;137:290
  4. Speroff L. The impact of the Women's Health Initiative on clinical practice. J Soc Gynecol Investig. 2002;9:251–253
  5. Humphrey LL, Chan B, Sox H. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002;137:273–284
  6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  7. Carney PA, Tosteson AN, Titus-Ernstoff L, et al. Hormone therapies in women aged 40 and older: prevalence and correlates of use. Maturitas. 2006;53:65–76
  8. Olesen AV, Johnsen SP, Mortensen JT, Boggild H, Olsen J, Sorensen HT. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand. 2005;84:639–644
  9. Donker GA, Spreeuwenberg P, Bartelds AI, van der Velden K, Foets M. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium. Fam Pract. 2000;17:508–513
  10. Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas. 1996;23:47–53
  11. Bermejo MJ, Perez IR. Physicians and the prescription of hormone replacement therapy in Spain. Health Policy. 2005;73:58–65
  12. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women The Women's Health in Lund Area (WHILA) Study. Menopause. 2000;7:273–281
  13. Levy BT, Ritchie JM, Smith E, Gray T, Zhang W. Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol. 2003;101:114–122
  14. Blumel JE, Castelo-Branco C, Riquelme R, et al. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause. 2002;9:377–380
  15. Blumel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone replacement therapy on postmenopausal women's health perceptions. Menopause. 2003;10:235–240
  16. Blumel JE, Castelo-Branco C, Chedraui PA, et al. Patients’ and clinicians’ attitudes after the Women's Health Initiative study. Menopause. 2004;11:57–61
  17. Grisso JA, Baum CR, Turner BJ. What do physicians in practice do to prevent osteoporosis?. J Bone Miner Res. 1990;5:213–219
  18. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med. 1990;5:464–469
  19. Rolnick SJ, Kopher RA, Compo RB, Kelley ME, DeFor TA. Provider attitudes and self-reported behaviors related to hormone replacement therapy. Menopause. 1999;6:257–263
  20. Saver BG, Taylor TR, Woods NF, Stevens NG. Physician policies on the use of preventive hormone therapy. Am J Prev Med. 1997;13:358–365
  21. McIntyre RS, Konarski JZ, Grigoriadis S, et al. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ (Journal de L’Association Medicale Canadienne). 2005;172:57–59
  22. Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Sulkes J, Phisher M. Gynecologists’ trends and attitudes toward prescribing hormone replacement therapy during menopause. Menopause. 2002;9:354–359
  23. Reynolds RF, Walker AM, Obermeyer CM, Rahman O, Guilbert D. Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO. J Clin Epidemiol. 2001;54:1056–1064
  24. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003;289:2827–2834
  25. Gabriel SR, Carmona L, Roque M, Sanchez GL, Bonfill X. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2005;[CD002229]
  26. Farquhar CMMJ, Lethaby A, Lamberts Q, Suckling JA, Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2005;[CD004143]
  27. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516–1520[see comment]
  28. Castelo-Branco C, Figueras F, Sanjuan A, et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause. 1999;6:307–311
  29. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545–553[see comment]
  30. Eddy DM. Variations in physician practice: the role of uncertainty. Health Aff. 1984;3:74–89
  31. Mort EA. Clinical decision-making in the face of scientific uncertainty: hormone replacement therapy as an example. J Fam Pract. 1996;42:147–151

PII: S0378-5122(06)00160-5

doi: 10.1016/j.maturitas.2006.04.023

Maturitas
Volume 55, Issue 4 , Pages 308-316 , 20 November 2006

Article Tools